Shedding light on testicular cancer

Nurse Practitioner

Volumn 36, Issue 7, 2011, Pages 32-39

  Zoltick, Barbara H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Germ cell tumor; Long term effects of chemotherapy; Nonseminoma; Seminoma; Testicular cancer

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER STAGING; GERM CELL TUMOR; HUMAN; MALE; METHODOLOGY; PROGNOSIS; RISK FACTOR; SELF EXAMINATION; TESTIS TUMOR; TREATMENT OUTCOME; WATCHFUL WAITING;

ADOLESCENT; ADULT; GERMINOMA; HUMANS; MALE; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SELF-EXAMINATION; TESTICULAR NEOPLASMS; TREATMENT OUTCOME; WATCHFUL WAITING; YOUNG ADULT;

EID: 80053086001     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1097/01.NPR.0000398870.16580.86     Document Type: Article

References (44)

1. Kondagunta GV, Sheinfeld J, Motzer RJ. Recommendations of follow-up after treatment of germ cell tumors. Semin Oncol. 2003;30(3):382-389.
2. Fleer J, Hoekstra HJ, Sleijfer DT, Hoekstra-Weebers JE. Quality of life of survivors of testicular germ cell cancer: A review of the literature. Support Care Cancer. 2004;12(7):476-486.
3. Kaufman MR, Chang SS. Short-and long-term complications of therapy for testicular cancer. Urol Clin North Am. 2007;34(2):259-268.
4. Einhorn LH. Treatment of testicular cancer: A new and improved model. J Clin Oncol. 1990;8(11):1777-1781.
5. Chaudhary UB, Haldas JR. Long-term complications of chemotherapy for germ cell tumours. Drugs. 2003;63(15):1565-1577.
6. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277-300.
7. Vaughn DJ, Gignac GA, Meadows AT. Long-term medical care of testicular cancer survivors. Ann Intern Med. 2002;136(6):463-470.
8. Garner MJ, Turner MC, Ghadirian P, Krewski D. Epidemiology of testicular cancer: An overview. Int J Cancer. 2005;116(3):331-339.
9. Herrinton LJ, Zhao W, Husson G. Management of cryptorchism and risk of testicular cancer. Am J Epidemiol. 2003;157(7):602-605.
10. Thorup J, McLachlan R, Cortes D, et al. What is new in cryptorchidism and hypospadias—a critical review on the testicular dysgenesis hypothesis. J Pediatr Surg. 2010;45(10):2074-2086.
11. Greene MH, Kratz CP, Mai PL, et al. Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype. Endocr Relat Cancer. 2010;17(2):R109-R121.
12. Bosl GJ, Sheinfeld J, Bajorin DF, et al. Cancer of the Testis. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 7th ed. Philadelphia, PA: Lippincott; 2005.
13. Presti JC, Genital Tumors. In: Tanagho EA, McAninch JW, eds. Smith's General Urology. 17th ed. New York, NY: McGraw Hill; 2008.
14. Dodd PM, Kelley K. Testicular Cancer. In: Lenhard RE, Osteen RT, Gansle T, eds. Clinical Oncology. 1st ed. Atlanta, GA: ACS; 2001:419-423
15. National Comprehensive Cancer Center (NCCN). 2011. Clinical Practice Guidelines in Oncology: Testicular Cancer. Version 2.2011. National Comprehensive Cancer Network.
16. Kovitz C, Logotheti C, Millikan RE. 2006. Testicular Cancer. In: Kantarjian HM, Wolff RA, Koller CA: MD Anderson Manual of Medical Oncology: McGraw-Hill.
17. Hartmann JT, Kanz L, Bokemeyer C. Diagnosis and treatment of patients with testicular germ cell cancer. Drugs. 1999;58(2):257-281.
18. Greene FL, Page DL, Fleming ID, et al, eds. 2002. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer;317-322.
19. International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol. 1997;15(2):594-603.
20. Baney TS, Cash J, Zoltick BH. 2009. Site Specific Cancer Series: Genitourinary Cancers. Held-Warmkessel J, ed. Pittsburgh, PA: Oncology Nursing Society;91-112.
21. de Wit R, Fizazi K. Controversies in the management of clinical stage I testis cancer. J Clin Oncol. 2006;24(35):5482-5492.
22. Choo R, Thomas G, Woo T, et al. Long-term outcome of postorchiectomy surveillance for stage I testicular seminoma. Int J Radiat Oncol Biol Phys. 2005;61(3):736-740.
23. Oosterhof GO, Verlind J. Testicular tumours (nonseminomatous). BJU Int. 2004;94(8):1196-1201.
24. Stephenson AJ, Tal R, Sheinfeld J. Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer. J Urol. 1996;176(5):1996-1999.
25. Masters JR, Koberle B. Curing metastatic cancer: Lessons from testicular germ-cell tumours. Nat Rev Cancer. 2003;3(7):517-525.
26. Benedetto P. Chemotherapy of testis cancer. Cancer Control. 1999;6(6):549-559.
27. Jones RH, Vasey PA. Part II: Testicular cancer-management of advanced disease. Lancet Oncol. 2003;4(12):738-747.
28. Kopp HG, Kuczyk M, Classen J, et al. Advances in the treatment of testicular cancer. Drugs. 2006;66(5):641-659.
29. Collette L, Sylvester RJ, Stenning SP, et al. Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party. J Natl Cancer Inst. 1999;91(10):839-846.
30. Horwich A, Shipley J, Huddart R. Testicular germ-cell cancer. Lancet. 2006;367(9512):754-765.
31. Oliver RT, Mason MD, Mead GM, et al. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: A randomised trial. Lancet. 2005;366(9482):293-300.
32. Oliver RT, Mason MD, Mead GM, et al. Radiotherapy versus carboplatin in adjuvant of stage I seminoma: A randomized trial. Lancet. 2005;366(9482)293-300.
33. Vaughn DJ. Chemotherapy for good-risk germ cell tumors: Current concepts and controversies. Urol Clin North Am. 2007;34(2):171-177.
34. Kondagunta V, Motzer RJ. Chemotherapy for advanced germ cell tumors. J Clin Oncol. 2006;24(35):5493-5502.
35. Fossa SD, de Wit R, Roberts JT, et al. Quality of life in good prognosis patients with metastatic germ cell cancer: A prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20). J Clin Oncol. 2003;21(6):1107-1118.
36. Camp-Sorrell D. Chemotherapy: Toxicity management. In: Yarbro CH, Frogge MH, Goodman M, et al, eds. Cancer Nursing: Principles and Practice. 5th ed. Sudbury, MA: Jones and Bartlett; 2000:444-486.
37. Hawkins C, Miaskowski C. Testicular cancer: A review. Oncol Nurs Forum. 1996;23(8):1203-1211.
38. McCullagh J, Lewis G. Testicular cancer: Epidemiology, assessment and management. Nurs Stand. 2005;19(25):45-53.
39. Morton G, Thomas GM. Testis. In: Perez C, Brady L, Halperin E, et al, eds. Principles and Practice of Radiation Oncology. 4th ed. Philadelphia, PA: Lippincott; 2004:1763-1784.
40. Zoltick BH, Jacobs LA, Vaughn DJ. Cardiovascular risk in testicular cancer survivors treated with chemotherapy: Incidence, significance, and practice implications. Oncol Nurs Forum. 2005;32(5):1005-1009.
41. Berger CC, Bokemeyer C, Schneider M, Kuczyk MA, Schmoll HJ. Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer. Eur J Cancer. 1995;31A(13-14):2229-2238.
42. Travis LB, Curtis RE, Storm H, et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Insti 1997;89(19):1429-1439.
43. Lampe H, Horwich A, Norman A, Nicholls J, Dearnaley DP. Fertility after chemotherapy for testicular germ cell cancers. J Clin Oncol. 1997;15(1):239-245.
44. Poirier SM, Rawl SM. Testicular germ cell cancer. In: Yarboro CH, Frogge MH, Goodman MG, et al, eds. Cancer Nursing: Principles and Practice. 5th ed. Sudbury, MA: Jones & Bartlett; 2000:1494-1510.